Dax (Performanceindex) (DAX.DAX30)

Close: 22 065.00 (+102.54), Apr 24, 2025
Positive

Low risk

Automatic technical analysis. Medium term, Apr 24, 2025

Investors have paid higher prices over time to buy Dax (Performanceindex) and the index is in a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The index has support at points 19700 and resistance at points 23400. The index is assessed as technically positive for the medium long term.

Recommendation one to six months: Positive (Score: 62)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.70%0.00+0.47%
5 days0.002.28%0.00+3.81%
22 days0.005.86%0.00-4.06%
66 days0.0011.52%0.00+5.55%

More analyses of Dax (Performanceindex)

chart Dax (Performanceindex) (DAX) Candlesticks 22 Days
Candlesticks
chart Dax (Performanceindex) (DAX) Short term
Short term: Weak Negative
chart Dax (Performanceindex) (DAX) Medium term
Medium term: Positive
chart Dax (Performanceindex) (DAX) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.